Drug recall · April 3, 2013
Venlafaxine Hydrochloride Tablets recall
Why: Failed Tablet/Capsule Specifications: Pharmacist complaint of an excessive amount of broken and/or chipped tablets in the bottle.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Venlafaxine Hydrochloride Tablets, 75 mg*, 100-count tablets per bottle, Rx only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534, NDC 68382-021-01.
- Lots / codes
Lot #: MM8490, Exp 09/14
- Quantity
- 13,320 bottles
- Company
- Zydus Pharmaceuticals USA Inc, Pennington, NJ
- Distribution
- Nationwide.
- Initiated
- March 5, 2013 · Voluntary: Firm initiated
- Classified
- March 25, 2013
- Reported
- April 3, 2013
- Ended
- May 4, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Venlafaxine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.